Semaglutide remains active within the body over prolonged periods, aiding in appetite control and stable blood sugar levels throughout the day
Patients should be made aware that they should contact their prescriber or GP immediately for advice
Currently available diagnostic methods, like breath testing, cannot accurately measure bacterial overgrowth
This results in increased feelings of satiety, reduced hunger, and lower calorie consumption, leading to significant weight loss
In this context, GLP-1 agonists represent a potentially valuable tool within a multimodal treatment approach, particularly for patients who have not achieved adequate weight loss through lifestyle modification alone
This is why once-weekly dosing works